Fusion Expression on the Esat-6 and cfp-10 Genes of Mycobacterium bovis in Escherichia coli

Based on the (Gly4Ser)3 linker, the esat-6 and cfp-10 gene were fused for raising the antigenicity of single antigen. The DNA fragments of esat-6 and cfp-10 were fused by splicing by overlapping extension (SOE) polymerase chain reaction (PCR),and the fusion gene esat-6-cfp-10 were cloned into pMD18-T vector, and then we got the recombinant plasmid pMD-esat-6-cfp-10. pMD-esat-6-cfp-10 and pET28a (+) were digested by BamHI and EcoRI double enzymes. The purified mpb esat-6-cfp-10 fusion gene was subcloned into the expression vector pET28a (+),and the prokaryotic expression vector pET-esat-6-cfp-10 was constructed. Plasmid containing pET-esat-6-cfp-10 was transformed into competence Escherichia coli BL21(DE3).The bacterium was induced by isopropyl-β-D-thiogalactopyranoside (IPTG) and analyzed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE),approximately 25 kDa exogenous protein was observed on the SDS-PAGE. The protein was analyzed by using Western-blotting. The results indicated that the protein was of antigenic activity of Mycobacterium bovis. These results could serve as a basis for further studies on the usefulness of the fusion gene and its expression product in the development of DNA vaccine; living carrier vaccine; subunit vaccine and diagnostic reagents against bovine tuberculosis.

[1]  R. Basaraba,et al.  Vaccines Displaying Mycobacterial Proteins on Biopolyester Beads Stimulate Cellular Immunity and Induce Protection against Tuberculosis , 2011, Clinical and Vaccine Immunology.

[2]  M. Peacey,et al.  Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid‐encoded cytokines against Mycobacterium bovis , 2010, Immunology and cell biology.

[3]  M. Tameris,et al.  The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. , 2010, American journal of respiratory and critical care medicine.

[5]  M. Palmer,et al.  An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. , 2007, Vaccine.

[6]  B. Buddle,et al.  Bacterial Polyester Inclusions Engineered To Display Vaccine Candidate Antigens for Use as a Novel Class of Safe and Efficient Vaccine Delivery Agents , 2009, Applied and Environmental Microbiology.

[7]  Z. Hasan,et al.  Differential Live Mycobacterium tuberculosis-, M. bovis BCG-, Recombinant ESAT6-, and Culture Filtrate Protein 10-Induced Immunity in Tuberculosis , 2009, Clinical and Vaccine Immunology.

[8]  Chunsheng Zhang,et al.  A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice. , 2008, Immunology letters.

[9]  B. Gicquel,et al.  A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). , 1998, Microbiology.

[10]  J. McNair,et al.  Development of a Skin Test for Bovine Tuberculosis for Differentiating Infected from Vaccinated Animals , 2010, Journal of Clinical Microbiology.

[11]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[12]  M. Palmer,et al.  Use of Recombinant ESAT-6:CFP-10 Fusion Protein for Differentiation of Infections of Cattle by Mycobacterium bovis and by M. avium subsp. avium and M. avium subsp. paratuberculosis , 2004, Clinical Diagnostic Laboratory Immunology.

[13]  B. Landry,et al.  A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity. , 2012, Vaccine.

[14]  S. Cole,et al.  Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays , 1999, Molecular microbiology.

[15]  D. Sherman,et al.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. , 2003, The Journal of infectious diseases.

[16]  R. Rappuoli,et al.  Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guérin Immunity1 , 2006, The Journal of Immunology.

[17]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[18]  G. Schoolnik,et al.  Comparative genomics of BCG vaccines by whole-genome DNA microarray. , 1999, Science.

[19]  S. Gordon,et al.  Screening of Predicted Secreted Antigens from Mycobacterium bovis Reveals the Immunodominance of the ESAT-6 Protein Family , 2010, Infection and Immunity.

[20]  Priscille Brodin,et al.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti , 2002, Molecular microbiology.

[21]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[22]  P. Barnes,et al.  Characterization of a Mycobacterium tuberculosis Peptide That Is Recognized by Human CD4+ and CD8+ T Cells in the Context of Multiple HLA Alleles1 , 2004, The Journal of Immunology.